For: | Manzhalii E, Moyseyenko V, Kondratiuk V, Molochek N, Falalyeyeva T, Kobyliak N. Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment. World J Hepatol 2022; 14(3): 634-646 [PMID: 35582294 DOI: 10.4254/wjh.v14.i3.634] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i3/634.htm |
Number | Citing Articles |
1 |
Frances Widjaja, Ivonne M. C. M. Rietjens. From-Toilet-to-Freezer: A Review on Requirements for an Automatic Protocol to Collect and Store Human Fecal Samples for Research Purposes. Biomedicines 2023; 11(10): 2658 doi: 10.3390/biomedicines11102658
|
2 |
Rachel Redfield, Nyan Latt, Santiago J. Munoz. Minimal Hepatic Encephalopathy. Clinics in Liver Disease 2024; 28(2): 237 doi: 10.1016/j.cld.2024.01.004
|
3 |
Ming Luo, Rui-Juan Xin, Fang-Rui Hu, Li Yao, Sheng-Juan Hu, Fei-Hu Bai. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy <i>via </i>the gut-liver-brain axis. World Journal of Gastroenterology 2023; 29(1): 144-156 doi: 10.3748/wjg.v29.i1.144
|
4 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Nazarii Kobyliak. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 275 doi: 10.1007/978-3-031-19564-8_10
|
5 |
Garima Mishra, Pradeep Singh, Mulugeta Molla, Yohannes Shumet Yimer, Subas Chandra Dinda, Phool Chandra, Bhuvnesh Kumar Singh, Samuel Berihun Dagnew, Abraham Nigussie Assefa, Amien Ewunetie. Harnessing the potential of probiotics in the treatment of alcoholic liver disorders. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212742
|
6 |
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
|
7 |
Luca Falzone, Alessandro Lavoro, Saverio Candido, Mario Salmeri, Antonino Zanghì, Massimo Libra.
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing
Escherichia coli
Nissle 1917 strain
. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2397874
|
8 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Oksana Sulaieva, Tetyana Falalyeyeva, Nazarii Kobyliak. Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.994911
|
9 |
Cynthia L. Hsu, Bernd Schnabl. The gut–liver axis and gut microbiota in health and liver disease. Nature Reviews Microbiology 2023; 21(11): 719 doi: 10.1038/s41579-023-00904-3
|
10 |
Jie Gao, Rui Nie, Hong Chang, Wei Yang, Qian Ren. A meta-analysis of microbiome therapies for hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2023; 35(9): 927 doi: 10.1097/MEG.0000000000002596
|
11 |
Fan Xue, Zheng He, De-Zheng Zhuang, Feng Lin. The influence of gut microbiota on circulating inflammatory cytokines and host: A Mendelian randomization study with meta-analysis. Life Sciences 2023; 332: 122105 doi: 10.1016/j.lfs.2023.122105
|
12 |
Ming Yang, Katina Massad, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li. Gut microbiota and metabolite interface-mediated hepatic inflammation. Immunometabolism 2024; 6(1): e00037 doi: 10.1097/IN9.0000000000000037
|
13 |
Xing Yang, Langhuan Lei, Wei Shi, Xiaozhen Li, Xiaozhi Huang, Liuyan Lan, Jiali Lin, Qiuyu Liang, Wei Li, Jianrong Yang. Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1379333
|
14 |
Kiran Heer, Manpreet Kaur, Dwinder Sidhu, Priyankar Dey, Saumya Raychaudhuri. Modulation of gut microbiome in response to the combination of Escherichia coli Nissle 1917 and sugars: a pilot study using host-free system reflecting impact on interpersonal microbiome. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1452784
|
15 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(642) |
Core Tip(575) |
Full Article(HTML)(3324)
|
Full Article with Cover (PDF)-2077K(108)
|
Full Article (Word)-351K(59)
|
Audio-395K(9)
|
Peer-Review Report-291K(64)
|
Answering Reviewers-97K(75)
|
Full Article (PDF)-967K(303)
|
Full Article (XML)-396K(79)
|
Times Cited (12)
|
Total Visits (7247)
|
Open
|
16 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 2024; 6(1): 64 doi: 10.3390/gidisord6010005
|
17 |
Tao Yang, Qijie Guan, Jin-Song Shi, Zheng-Hong Xu, Yan Geng. Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(5): 166664 doi: 10.1016/j.bbadis.2023.166664
|
18 |
Fernanda Raya Tonetti, Alvaro Eguileor, Marko Mrdjen, Vai Pathak, Jared Travers, Laura E. Nagy, Cristina Llorente. Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease. Hepatology 2024; 80(6): 1342 doi: 10.1097/HEP.0000000000000924
|